Xeris Biopharma Holdings, Inc. XERS
16.52 USD +0.69 (+4.36%)
At closeNov 11, 2026, 7:40 PM EST
16.57 +0.05 +0.30%
After hours · Nov 11, 7:40 PM ET
15.93 Day range 16.57
5.25 52-week range 16.57
- YTD
- +110.45%
- 1 year
- +122.04%
Revenue & Expenses
Latest period ending Dec 31, 2025 · select a line to chart its full history
Annual income statement
| Fiscal year | FY 2025 Dec 31, 2025 | FY 2024 Dec 31, 2024 | FY 2023 Dec 31, 2023 | FY 2022 Dec 31, 2022 | FY 2021 Dec 31, 2021 |
|---|---|---|---|---|---|
| 291.85M | 203.07M | 163.91M | 110.25M | 49.59M | |
| 291.85M | 203.07M | 163.91M | 110.25M | 49.59M | |
| 42.57M | 36.83M | 28.64M | 22.63M | 13.32M | |
| 249.28M | 166.24M | 135.27M | 87.61M | 36.27M | |
| 224.38M | 199.88M | 179.28M | 169.55M | 151.43M | |
| 31.16M | 25.56M | 22.34M | 20.97M | 25.16M | |
| 182.37M | 163.48M | 146.09M | 137.75M | 125.72M | |
| 24.90M | -33.65M | -44.01M | -81.94M | -115.16M | |
| 29.08M | 30.48M | 26.61M | 14.10M | 7.18M | |
| 554.00K | -54.84M | -62.26M | -94.66M | -122.72M | |
| 554.00K | -54.84M | -62.26M | -94.66M | -122.72M | |
| 554.00K | -54.84M | -62.26M | -94.66M | -122.72M | |
| 554.00K | -54.84M | -62.26M | -94.66M | -122.72M | |
| 29.64M | -26.62M | -36.90M | -81.98M | -115.55M | |
| 29.64M | -26.62M | -36.90M | -81.98M | -115.55M | |
| 160.43M | 146.77M | 137.67M | 135.63M | 79.03M | |
| 172.74M | 146.77M | 137.67M | 135.63M | 79.03M |